Overview

• Anne Wojcicki’s TTAM Research Institute outbid Regeneron with a $305 million offer to acquire substantially all of 23andMe’s assets in a bankruptcy auction reopened by a federal judge.
• The acquisition remains subject to approval by the U.S. Bankruptcy Court for the Eastern District of Missouri.
• Since the Chapter 11 filing in March, nearly 1.9 million customers—about 15% of the user base—have requested deletion of their genetic data.
• A coalition of 27 states and the District of Columbia has sued to block the sale of 23andMe’s genetic database, arguing it violates state privacy laws without explicit customer consent.
• Congressional Democrats have demanded assurances from potential buyers on continued data deletion rights, law enforcement sharing policies, and transparency regarding third-party access to genetic information.